◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › 0-9 › 1513

Livzon Pharmaceutical Group Inc. (1513) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-30

Livzon Pharmaceutical Group Inc. (1513) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Zhuhai, China with about 8,878 employees. Its market capitalization is roughly HK$20 billion. In the fiscal year ended 2025-12-31, 1513 reported CNY 12.0B in revenue and CNY 2.0B in net income.

Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People's Republic of China and internationally.

Interactive charts & full statements → Open the 1513 valuation workbench →

1513 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-31
Total RevenueCNY 12.0BCNY 11.8BCNY 12.4BCNY 12.6B
Gross ProfitCNY 7.9BCNY 7.7BCNY 8.0BCNY 8.2B
Operating Income (EBIT)CNY 2.8BCNY 2.8BCNY 2.4BCNY 2.2B
Net IncomeCNY 2.0BCNY 2.1BCNY 2.0BCNY 1.9B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1513 Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-06-302025-03-31
Total RevenueCNY 2.1BCNY 2.9BCNY 2.9BCNY 3.1BCNY 3.2B
Gross ProfitCNY 1.2BCNY 1.9BCNY 1.9BCNY 2.1BCNY 2.1B
Operating Income (EBIT)CNY 437MCNY 834MCNY 478MCNY 762MCNY 904M
Net IncomeCNY 355MCNY 577MCNY 269MCNY 644MCNY 637M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1513 Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid(CNY 1.0B)(CNY 1.3B)(CNY 1.6B)(CNY 1.3B)—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1513 Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-06-302025-03-31
Dividends Paid(CNY 852M)(CNY 13M)(CNY 12M)(CNY 667M)(CNY 12M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1513 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 24.0BCNY 24.5BCNY 25.0BCNY 24.9B—
Total LiabilitiesCNY 8.4BCNY 9.6BCNY 10.3BCNY 9.9B—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1513 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← 1511All “0-9” companies1514 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.